GENEFAB News and Resources

GeneFab, a cell and gene therapy-focused contract research, development, and manufacturing organisation (CRDMO), has entered into a partnership with RegCell to advance clinical manufacturing for regulatory T cell (Treg) therapies. The agreement supports RegCell’s expansion into the U.S. as it